A range of emerging technologies, including biotechnology, nanotechnology, and synthetic biology, are expected to transform society. Handling the development and regulation of these promising technologies is a daunting task as the risks presented will not be understood until the technologies are further developed. This paper proposes a new governance model that seeks manage the dynamic of emerging technology promise versus risk by moving the point of first governance earlier in a technology's development, but enabling the governance structure to evolve after formation. The model aims to turn some of the greatest challenges of managing emerging technologies - scientific uncertainty and the disruption of extant regulatory systems - on their head to create incentives for widespread stakeholder cooperation to produce more proactive, flexible governance.
No takes yet. Share an insight, caveat, or question.
Gregory N. Mandel (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: